A color discriminating broad range cell staining technology for early detection of cell transformation
- PMID: 20023366
- PMCID: PMC2797300
- DOI: 10.4103/1477-3163.58372
A color discriminating broad range cell staining technology for early detection of cell transformation
Abstract
Background: Advanced diagnostic tools stand today at the heart of successful cancer treatment. CellDetect(R) is a new histochemical staining technology that enables color discrimination between normal cells and a wide variety of neoplastic tissues. Using this technology, normal cells are colored blue/green, while neoplastic cells color red. This tinctorial difference coincides with clear morphological visualization properties, mainly in tissue samples. Here we show that the CellDetect(R) technology can be deployed to distinguish normal cells from transformed cells and most significantly detect cells in their early pre-cancerous transformed state.
Materials and methods: In tissue culture, we studied the ability of the CellDetect(R) technology to color discriminate foci in a number of two stage transformation systems as well as in a well defined cellular model for cervical cancer development, using HPV16 transformed keratinocytes.
Results: In all these cellular systems, the CellDetect(R) technology was able to sensitively show that all transformed cells, including pre-cancerous HPV 16 transformed cells, are colored red, whereas normal cells are colored blue/green. The staining technology was able to pick up: (i) early transformation events in the form of small type 1 foci (non-invasive, not piled up small, with parallel alignment of cells), and (ii) early HPV16 transformed cells, even prior to their ability to form colonies in soft agar. The study shows the utility of the CellDetect(R) technology in early detection of transformation events.
Figures


Similar articles
-
Novel dual-function CellDetect® staining technology: wedding morphology and tinctorial discrimination to detect cervical neoplasia.Diagn Pathol. 2010 Nov 11;5:70. doi: 10.1186/1746-1596-5-70. Diagn Pathol. 2010. PMID: 21070653 Free PMC article.
-
Diagnostic value comparison of CellDetect, fluorescent in situ hybridization (FISH), and cytology in urothelial carcinoma.Cancer Cell Int. 2021 Sep 6;21(1):465. doi: 10.1186/s12935-021-02169-3. Cancer Cell Int. 2021. PMID: 34488763 Free PMC article.
-
A novel urine cytology stain for the detection and monitoring of bladder cancer.J Urol. 2014 Dec;192(6):1628-32. doi: 10.1016/j.juro.2014.06.079. Epub 2014 Jun 30. J Urol. 2014. PMID: 24992334
-
The CGL1 (HeLa × Normal Skin Fibroblast) Human Hybrid Cell Line: A History of Ionizing Radiation Induced Effects on Neoplastic Transformation and Novel Future Directions in SNOLAB.Radiat Res. 2017 Oct;188(4.2):512-524. doi: 10.1667/RR14911.1. Epub 2017 Sep 5. Radiat Res. 2017. PMID: 28873027 Review.
-
[HPV16 participates in progressive transformation of normal epidermal cells].Gan To Kagaku Ryoho. 1989 Mar;16(3 Pt 2):549-61. Gan To Kagaku Ryoho. 1989. PMID: 2539784 Review. Japanese.
Cited by
-
Detection of cell carcinogenic transformation by a quadruplex DNA binding fluorescent probe.PLoS One. 2014 Jan 28;9(1):e86143. doi: 10.1371/journal.pone.0086143. eCollection 2014. PLoS One. 2014. PMID: 24489694 Free PMC article.
-
Novel dual-function CellDetect® staining technology: wedding morphology and tinctorial discrimination to detect cervical neoplasia.Diagn Pathol. 2010 Nov 11;5:70. doi: 10.1186/1746-1596-5-70. Diagn Pathol. 2010. PMID: 21070653 Free PMC article.
References
-
- Etzioni R, Urban N, Ramsey S, McIntosh M, Schwartz S, Reid B, et al. The case for early detection. Nat Rev Cancer. 2003;3:243–52. - PubMed
-
- Pollak MN, Foulkes WD. Challenges to cancer control by screening. Nat Rev Cancer. 2003;3:297–303. - PubMed
-
- Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin. 2006;56:11–25. quiz 49-50. - PubMed
-
- Tanaka M. Strategies for early diagnosis and treatment of pancreatic cancer. Nippon Shokakibyo Gakkai Zasshi. 2008;105:26–30. - PubMed
-
- Ohira T, Suga Y, Nagatsuka Y, Usuda J, Tsuboi M, Hirano T, et al. Early-stage lung cancer: Diagnosis and treatment. Int J Clin Oncol. 2006;11:9–12. - PubMed
LinkOut - more resources
Full Text Sources